| | The fourth wave of COVID-19 infections is receding in France but is not over yet, French Health Minister Olivier Veran said on Thursday. | | | A U.S. appeals court on Thursday threw out a $1.2 billion ruling against Gilead Sciences Inc , finding a patent on a cancer therapy it was accused of infringing was invalid, in a blow to rival Bristol Myers Squibb Co . | | | Japan suspended the use of 1.63 million doses of Moderna Inc's COVID-19 vaccine on Thursday, more than a week after the domestic distributor received reports of contaminants in some vials. | | | Students and teachers who have not been inoculated against COVID-19 or recovered from the disease will have to take weekly tests, the Slovenian government said on Thursday as infections in the country rose to their highest since May. | | | Hundreds of Greek frontline health workers protested on Thursday against a plan to make COVID-19 vaccinations mandatory for the care sector as infection rates remained high. | | | No safety or efficacy issues have been identified in relation to the Moderna vaccine so far, Spanish pharmaceutical firm Rovi said on Thursday, after Japan suspended the use of 1.63 million Moderna doses due to reports of contamination. | | | Italy reported 43 coronavirus-related deaths on Thursday, compared with 59 the day before, the health ministry said, while the daily tally of new infections fell to 7.221from 7,548. | | | The European Medicines Agency (EMA) said on Thursday it was investigating a contamination incident in the manufacturing of Moderna COVID-19 vaccines to assess whether there was an impact on EU supply. | | | Britain reported 38,281 new cases of COVID-19, government data showed on Thursday, while a further 140 people were recorded as having died within 28 days of a positive test. | | | The World Health Organization's pandemic programme plans to ship 100 million doses of the Sinovac and Sinopharm COVID-19 shots by the end of next month, mostly to Africa and Asia, in its first delivery of Chinese vaccines, a WHO document shows. | | | | |